ASRNL Stock Analysis: ASR Nederland | AS
Insurance - Diversified | AS, Netherlands | Market Cap: 14.467m EUR | 12M Return: 29.6% | NL0011872643 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.2M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ASR Nederland N.V. is a Utrecht-based financial services group founded in 1720, making it one of the oldest insurance companies in Europe. Originally named Fortis Verzekeringen Nederland, the company adopted its current name in October 2008 following its separation from the former Fortis banking group.
The company operates across five segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. Its product range covers disability, property and casualty, health, term life, and funeral insurance, alongside pension products and residential mortgages offered under the a.s.r. and Aegon brands. The mortgage book includes specialised offerings for first-time buyers, sustainable home modifications, and senior citizens.
Its asset management arm invests across listed instruments (corporate and government bonds, equities) and unlisted sector funds covering Dutch retail, residential, office, science park, and agricultural real estate, as well as renewable energy assets such as wind, solar, and energy storage. The Distribution and Services segment extends into workplace health and safety services through brands such as ArboNed and Mensely.
As a multi-line insurer, ASR combines life and non-life underwriting with asset management and mortgage origination, a vertically integrated model that allows the group to retain investment and fee income across the customer relationship. Operating exclusively in the Dutch market, the company is a Large Cap constituent in the Financials sector.
- Aegon Netherlands pension acquisition expands premium income and scale
- Higher interest rates boost investment portfolio yields and mortgage margins
- Solvency II ratio strength supports sustained dividend and buyback program
| Net Income: 1.26b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.88 > 1.0 |
| NWC/Revenue: -58.68% < 20% (prev 0.46%; Δ -59.15% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.37b > Net Income 1.26b |
| Net Debt (6.74b) to EBITDA (1.74b): 3.87 < 3 |
| Current Ratio: 0.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (222.1m) vs 12m ago 4.95% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 14.31% > 50% (prev 11.63%; Δ 2.69% > 0%) |
| Interest Coverage Ratio: 0.26 > 6 (EBIT TTM 1.59b / Interest Expense TTM 6.05b) |
| A: -0.08 (Total Current Assets 4.10b - Total Current Liabilities 16.1b) / Total Assets 145b |
| B: 0.03 (Retained Earnings 4.71b / Total Assets 145b) |
| C: 0.01 (EBIT TTM 1.59b / Avg Total Assets 143b) |
| D: 0.07 (Book Value of Equity 8.97b / Total Liabilities 136b) |
| Altman-Z'' = -0.29 = B |
| DSRI: 3.0 (Receivables 345.0m/72.0m, Revenue 20.5b/16.4b) |
| GMI: 1.0 (GM 100.0% / 100.0%) |
| AQI: 1.02 (AQ_t 0.97 / AQ_t-1 0.95) |
| SGI: 1.25 (Revenue 20.5b / 16.4b) |
| TATA: -0.00 (NI 1.26b - CFO 1.37b) / TA 145b) |
| Beneish M = -1.19 (Cap -4..+1) = D |
As of September 02, 2026, the stock is trading at EUR 72.82 with a total of 463,320 shares traded. Over the past week, the price has changed by +4.94%, over one month by +5.30%, over three months by +17.09% and over the past year by +29.60%.
Current recommended Stop Loss: 70.40 (which is 3.3% or 2.3 ATR below the current price).
ASR Nederland has no consensus analysts rating.
P/E Trailing = 13.965
P/E Forward = 11.8343
P/S = 0.7781
P/B = 1.3614
Revenue TTM = 20.5b EUR
EBIT TTM = 1.59b EUR
EBITDA TTM = 1.74b EUR
Long Term Debt = 8.91b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 70.0m EUR (from shortTermDebt, last fiscal year)
Debt = 10.5b EUR (from shortLongTermDebtTotal, last quarter) + Leases 120.0m
Net Debt = 6.74b EUR (calculated: Debt 10.5b - CCE 3.76b)
Enterprise Value = 21.2b EUR (14.5b + Debt 10.5b - CCE 3.76b)
Interest Coverage Ratio = 0.26 (Ebit TTM 1.59b / Interest Expense TTM 6.05b)
EV/FCF = 15.78x (Enterprise Value 21.2b / FCF TTM 1.34b)
FCF Yield = 6.34% (FCF TTM 1.34b / Enterprise Value 21.2b)
FCF Margin = 6.56% (FCF TTM 1.34b / Revenue TTM 20.5b)
Net Margin = 6.16% (Net Income TTM 1.26b / Revenue TTM 20.5b)
Gross Margin = unknown ((Revenue TTM 20.5b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.15 (Enterprise Value 21.2b / Total Assets 145b)
Interest Expense / Debt = 57.68% (Interest Expense 6.05b / Debt 10.5b)
Taxrate = 21.95% (349.0m / 1.59b)
NOPAT = 1.24b (EBIT 1.59b * (1 - 21.95%))
Current Ratio = 0.25 (Total Current Assets 4.10b / Total Current Liabilities 16.1b)
Debt / Equity = 1.17 (Debt 10.5b / totalStockholderEquity, last quarter 8.97b)
Debt / EBITDA = 3.87 (Net Debt 6.74b / EBITDA 1.74b)
Debt / FCF = 5.01 (Net Debt 6.74b / FCF TTM 1.34b)
Total Stockholder Equity = 9.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.88% (Net Income 1.26b / Total Assets 145b)
RoE = 13.56% (Net Income TTM 1.26b / Total Stockholder Equity 9.31b)
RoCE = 8.73% (EBIT 1.59b / Capital Employed (Equity 9.31b + L.T.Debt 8.91b))
RoIC = 0.97% (NOPAT 1.24b / Invested Capital 128b)
WACC = 3.76% (E(14.5b)/V(25.0b) * Re(6.48%) + (debt cost/tax rate unavailable))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 65.80 | Cagr: 23.19%
[DCF] Terminal Value 77.97% ; FCFF base≈829.2m ; Y1≈950.5m ; Y5≈1.40b
[DCF] Fair Price = 71.02 (EV 21.1b - Net Debt 6.74b = Equity 14.3b / Shares 201.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -60.73 | EPS CAGR: -24.20% | SUE: N/A | # QB: 0
Revenue Correlation: 90.60 | Revenue CAGR: 26.90% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=6.42 | Chg30d=+6.80% | Revisions=-38% | GrowthEPS=+1.0% | GrowthRev=+17.6%
EPS next Year (2027-12-31): EPS=6.34 | Chg30d=+0.76% | Revisions=-29% | GrowthEPS=-1.3% | GrowthRev=-2.1%
[Analyst] Revisions Ratio: -42% (up=2, down=7)